Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79,794,643
-
Total 13F shares
-
12,769,825
-
Share change
-
+379,114
-
Total reported value
-
$41,630,918
-
Put/Call ratio
-
0%
-
Price per share
-
$3.26
-
Number of holders
-
59
-
Value change
-
+$1,194,498
-
Number of buys
-
22
-
Number of sells
-
22
Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q1 2020
As of 31 Mar 2020 Niagen Bioscience, Inc. - Common Stock (NAGE) had 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,769,825 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, ICONIQ Capital, LLC, Tieton Capital Management, LLC, Uniplan Investment Counsel, Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Sycale Advisors (NY) LLC, and FIRST REPUBLIC INVESTMENT MANAGEMENT, INC..
This table shows 59 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.